paclitaxel has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belum, VR; Dalenc, F; Deslandres, M; Eche, A; Gladieff, L; Lacouture, ME; Lebœuf, NR; Montastruc, M; Roche, H; Sibaud, V; Vigarios, E | 1 |
Bagot, M; Cosnes, A; Duong, TA; Gantzer, A; Ortonne, N; Regnier, S; Wolkenstein, P | 1 |
Cary-Ten Have Dallinga, M; El Kouri, C; Lortholary, A; Morineau, N; Ramée, JF | 1 |
Adachi, A; Horikawa, T | 1 |
2 review(s) available for paclitaxel and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Dermatological adverse events with taxane chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Docetaxel; Drug Eruptions; Edema; Humans; Lupus Erythematosus, Cutaneous; Nail Diseases; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Taxoids | 2016 |
[Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Topics: Adenocarcinoma; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Mastectomy; Middle Aged; Paclitaxel; Paraneoplastic Syndromes; Ribonucleoproteins; Salvage Therapy; Tamoxifen; Taxoids; Trastuzumab | 2011 |
2 other study(ies) available for paclitaxel and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
[Paclitaxel-induced lupus].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Betamethasone; Biopsy; Drug Therapy, Combination; Erythropoietin; Female; Humans; Lupus Erythematosus, Cutaneous; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Recurrence; Skin; Treatment Outcome | 2007 |
Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody.
Topics: Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Arm; Breast Neoplasms; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Paclitaxel; Sjogren's Syndrome; Skin | 2007 |